0001144204-13-031619.txt : 20130524
0001144204-13-031619.hdr.sgml : 20130524
20130524164956
ACCESSION NUMBER: 0001144204-13-031619
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130523
FILED AS OF DATE: 20130524
DATE AS OF CHANGE: 20130524
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DERMA SCIENCES, INC.
CENTRAL INDEX KEY: 0000892160
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 232328753
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6095144744
MAIL ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DERMA SCIENCES INC
DATE OF NAME CHANGE: 19940513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAUL AMY S
CENTRAL INDEX KEY: 0001235355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13070
FILM NUMBER: 13872709
MAIL ADDRESS:
STREET 1: C.R. BARD, INC.
STREET 2: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
v346171_form4.xml
FORM 4
X0306
4
2013-05-23
0
0000892160
DERMA SCIENCES, INC.
DSCI
0001235355
PAUL AMY S
2591 BRENTWOOD DRIVE
HOLLADAY
UT
84121
1
0
0
0
Common Stock
2013-05-23
4
A
0
10000
0
A
10000
D
Stock Option (right to buy)
13.76
2013-05-23
4
A
0
15000
0
A
2014-05-23
2023-05-23
Common Stock
15000
15000
D
The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan and will vest as to 25% of the grant on the first, second, third and fourth anniversaries of the grant date so long as the reporting person remains a director of the issuer.
The restricted stock units were granted under the issuer's equity incentive plan and without payment of consideration in connection with the reporting person's appointment to the board of directors of the issuer.
The options were issued under the issuer's equity incentive plan and will vest as to 25% of the grant on the first, second, third and fourth anniversaries of the grant date so long as the reporting person remains a director of the issuer.
The options were granted under the issuer's equity incentive plan and without payment of consideration in connection with the reporting person's appointment to the board of directors of the issuer.
/s/ Amy S. Paul
2013-05-23